CD4+ T cell receptor specific for carrier-peptide-MHC II complexes (CD4+ TCR-pMHC II)

CD4+ T cell receptors (TCRs) specific for carrier-peptide-MHC II complexes are specialized immune receptors that recognize processed protein fragments presented on the surface of antigen-presenting cells (Source: Nature Reviews Immunology, 2017). These receptors play a pivotal role in the adaptive immune response by facilitating the activation of helper T cells, which are essential for orchestrating both humoral and cellular immunity (Source: Janeway's Immunobiology, 9th Edition). The carrier-peptide aspect refers to peptides derived from highly immunogenic proteins, such as Tetanus Toxoid or CRM197, which are used in conjugate vaccines to provide T-cell help for antigens that cannot independently stimulate a T-cell response (Source: Vaccine, 2021). Upon binding to the peptide-MHC II complex, the TCR initiates a signaling cascade involving the CD3 complex, leading to the secretion of cytokines like IL-2 and IFN-gamma and the expression of surface markers like CD40L (Source: Cell, 2019). In clinical practice, these receptors are targeted to enhance vaccine efficacy and are also being explored in TCR-engineered T cell therapies for cancer (Source: Frontiers in Immunology, 2022). However, inappropriate activation of these receptors can lead to autoimmune disorders or severe allergic reactions, necessitating careful design of therapeutic interventions (Source: Journal of Clinical Investigation, 2020).

Other names

MHC class II-restricted T-cell receptorCarrier-specific T-cell receptorCD4+ T-cell receptorpMHCII-TCR complex

Activation of CD4+ helper T cells through the recognition of carrier-derived peptides presented on MHC class II molecules, which triggers cytokine release and provides necessary signals for B cell maturation and antibody production.